Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Liraglutide> ?p ?o. }
Showing items 1 to 57 of
57
with 100 items per page.
- Liraglutide abstract "Liraglutide (NN2211), marketed under the brand name Victoza, is a long-acting glucagon-like peptide-1 agonist (GLP-1 agonist) developed by Novo Nordisk for the treatment of type 2 diabetes. The product was approved by the European Medicines Agency (EMA) on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010.Liraglutide is marketed under the brandname Victoza in the U.S., India, Canada, Europe and Japan. It has been launched in Germany, Denmark, the Netherlands, the United Kingdom, Ireland, Sweden, Japan, Canada, the United States, France, Malaysia and Singapore.Phase I trials of an oral variant of Victoza (NN9924) started in 2010.".
- Liraglutide atcPrefix "A10BX07".
- Liraglutide casNumber "204656-20-2".
- Liraglutide drugbank "DB06655".
- Liraglutide pubchem "44147092".
- Liraglutide thumbnail Liraglutide.png?width=300.
- Liraglutide wikiPageID "15809706".
- Liraglutide wikiPageRevisionID "600968428".
- Liraglutide atcPrefix "A10BX07".
- Liraglutide caption "NMR structure of liraglutide. PDB entry".
- Liraglutide casNumber "204656".
- Liraglutide chemicalFormula "C172H265N43O51".
- Liraglutide drugName "Liraglutide".
- Liraglutide drugbank "DB06655".
- Liraglutide hasPhotoCollection Liraglutide.
- Liraglutide legalStatus "Rx-only".
- Liraglutide molecularWeight "3751.202".
- Liraglutide pubchem "44147092".
- Liraglutide tradename "Victoza".
- Liraglutide subject Category:Anti-diabetic_drugs.
- Liraglutide subject Category:Diabetes.
- Liraglutide subject Category:Peptide_hormones.
- Liraglutide type Abstraction100002137.
- Liraglutide type BodySubstance105263850.
- Liraglutide type Hormone105407119.
- Liraglutide type LiquidBodySubstance105397468.
- Liraglutide type Matter100020827.
- Liraglutide type Part113809207.
- Liraglutide type PeptideHormones.
- Liraglutide type PhysicalEntity100001930.
- Liraglutide type Relation100031921.
- Liraglutide type Secretion105404728.
- Liraglutide type Substance100019613.
- Liraglutide type Drug.
- Liraglutide type DrugProduct.
- Liraglutide type FunctionalSubstance.
- Liraglutide comment "Liraglutide (NN2211), marketed under the brand name Victoza, is a long-acting glucagon-like peptide-1 agonist (GLP-1 agonist) developed by Novo Nordisk for the treatment of type 2 diabetes. The product was approved by the European Medicines Agency (EMA) on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010.Liraglutide is marketed under the brandname Victoza in the U.S., India, Canada, Europe and Japan.".
- Liraglutide label "Liraglutida".
- Liraglutide label "Liraglutida".
- Liraglutide label "Liraglutide".
- Liraglutide label "Liraglutide".
- Liraglutide label "Liraglutide".
- Liraglutide label "リラグルチド".
- Liraglutide label "利拉鲁肽".
- Liraglutide sameAs Liraglutida.
- Liraglutide sameAs Liraglutide.
- Liraglutide sameAs Liraglutide.
- Liraglutide sameAs リラグルチド.
- Liraglutide sameAs Liraglutida.
- Liraglutide sameAs m.03qcmpw.
- Liraglutide sameAs Q2526479.
- Liraglutide sameAs Q2526479.
- Liraglutide sameAs Liraglutide.
- Liraglutide wasDerivedFrom Liraglutide?oldid=600968428.
- Liraglutide depiction Liraglutide.png.
- Liraglutide isPrimaryTopicOf Liraglutide.
- Liraglutide name "Liraglutide".